NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Segregation of Duties issues will continue to exists regardless if a CFO hired tomorrow or next year. All of the language in the 10-K about potentially material weakness is added more to protect firms against investor lawsuits than anything else. To believe that a CFO would add more "credibility" to the numbers is pretty ridiculous.

NWBO does not have the cash or sales to support the proper organization that can appropriately comply to all SOX regulations. That is a fact.

Personally, right now, I am not sure how valuable a CFO would be to the organization given the amount of work available and need to minimize cash burn.

Thus, ultimately it comes down to a level of comfort for each individual investor regarding a CFO. If you feel:
1. Strongly that every company needs a CFO, then the appropriate course of action is to consider shorting NWBO.
2. It would be nice to have a CFO, but not necessary, then the appropriate course of action is to wait for NWBO to hire a CFO and then buy the shares.
3. Indifferent about a CFO right now (but might need one later on in the future), then hold your position or buy more shares.

If NWBO's price does crash because of the CFO issue, then it will be experience that we can all learn from and adjust our risk/reward profile as necessary.